Deverra Therapeutics Granted FDA Fast Track Designation for DVX101 ... pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
1. Significantly more patients in the imetelstat group achieved RBC transfusion independence at 8 weeks after treatment compared to placebo. 2. Grade 3-4 treatment-related adverse events were greater in the imetelstat group. Evidence Rating Level: 1 (Excellent) Study Rundown: Patients with red blood cell transfusion-dependent lower-risk myelodysplastic syndromes (LR-MDS) face unmet medical needs when unresponsive to erythropoiesis-stimulating
New York Trial Court Weighs in on Summary Judgment Motions Filed in Benzene Case harrismartin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from harrismartin.com Daily Mail and Mail on Sunday newspapers.